The anemia of chronic disease diagnostic workup hinges on one critical distinction: separating it from iron deficiency anemia. Both conditions cause low serum iron, which trips up clinicians constantly. The key difference? In anemia of chronic disease (ACD), your body has plenty of iron — it’s just locked away in storage, unavailable for making red blood cells. Ferritin is normal or elevated (typically >100 ng/mL), while in true iron deficiency, ferritin drops below 30 ng/mL. That single lab value changes the entire treatment approach.
ACD is the second most common anemia worldwide, affecting up to 40% of hospitalized patients with chronic inflammatory conditions. If you’re working up a patient with mild-to-moderate anemia alongside rheumatoid arthritis, cancer, chronic kidney disease, or a lingering infection like tuberculosis, ACD should be at the top of your differential. Here’s exactly how to confirm it.
What Causes Anemia of Chronic Disease?
The driving force behind ACD is hepcidin, a hormone produced by the liver in response to inflammatory cytokines — particularly interleukin-6 (IL-6). Hepcidin acts as the body’s iron gatekeeper. When inflammation ramps up IL-6, hepcidin levels surge, which does two things:
- Blocks iron absorption from the gut by degrading ferroportin on enterocytes
- Traps iron inside macrophages and hepatocytes, preventing its release into the bloodstream
The result is a functional iron deficiency — the bone marrow is starved of iron even though the body’s total iron stores are adequate or even high. On top of this, the inflammatory state blunts the kidneys’ erythropoietin (EPO) response and shortens red blood cell lifespan from the normal ~120 days to roughly 60–90 days.
Common Conditions That Trigger ACD
- Autoimmune diseases: Rheumatoid arthritis, lupus, inflammatory bowel disease
- Chronic infections: Tuberculosis, HIV, osteomyelitis, endocarditis
- Malignancies: Lymphoma, lung cancer, renal cell carcinoma
- Chronic kidney disease: Especially stages 3–5, where EPO production also drops
- Heart failure: Affects 30–50% of CHF patients
The Anemia of Chronic Disease Diagnostic Lab Panel
A complete blood count (CBC) is your starting point. ACD typically shows a hemoglobin between 8–11 g/dL with a normocytic, normochromic picture (MCV 80–100 fL). In about 20–30% of cases, it can be mildly microcytic, which further muddies the water with iron deficiency.
The real diagnostic power comes from iron studies. Here’s the pattern you need to recognize:
| Lab Test | Anemia of Chronic Disease | Iron Deficiency Anemia | ACD + Iron Deficiency (Mixed) |
|---|---|---|---|
| Serum Iron | Low (<60 µg/dL) | Low (<60 µg/dL) | Low |
| Ferritin | Normal/High (30–200+ ng/mL) | Low (<30 ng/mL) | 30–100 ng/mL (ambiguous) |
| TIBC | Low/Normal (<300 µg/dL) | High (>400 µg/dL) | Low/Normal |
| Transferrin Saturation | 10–20% | <10% | Low |
| Soluble Transferrin Receptor (sTfR) | Normal | Elevated | Elevated |
| Reticulocyte Count | Low/Normal | Low | Low |
| CRP / ESR | Elevated | Normal | Elevated |
The Ferritin Trap: When Values Are Ambiguous
Ferritin is an acute phase reactant — it rises with inflammation regardless of iron status. This means a patient can have genuine iron deficiency and a “normal” ferritin because inflammation artificially inflates the number. In the setting of chronic disease, a ferritin between 30–100 ng/mL is a diagnostic gray zone that suggests possible coexisting iron deficiency.
When you’re stuck in that gray zone, two tests help clarify:
- Soluble transferrin receptor (sTfR): Elevated in true iron deficiency, normal in pure ACD. The sTfR/log ferritin ratio (also called the Thomas plot or ferritin index) above 2.0 strongly suggests concurrent iron deficiency.
- Reticulocyte hemoglobin content (CHr or Ret-He): Values below 28 pg suggest functional iron deficiency requiring iron supplementation, even if ferritin looks “normal.”
Why TIBC Matters More Than You Think
Total iron-binding capacity (TIBC) reflects how hungry the body is for iron. In iron deficiency, the body ramps up transferrin production to scavenge every available iron molecule, pushing TIBC above 400 µg/dL. In ACD, the liver suppresses transferrin production (alongside increasing hepcidin), so TIBC stays low or normal. This divergent pattern is one of the most reliable ways to tell the two conditions apart at the bedside.
Treatment: Treat the Disease, Not Just the Anemia
The cornerstone of ACD management is treating the underlying condition. When the inflammatory driver resolves — whether through disease-modifying therapy for RA, antibiotics for chronic infection, or chemotherapy for malignancy — the anemia often improves on its own.
Specific interventions include:
- Erythropoiesis-stimulating agents (ESAs): Considered when hemoglobin drops below 10 g/dL in CKD or cancer-related ACD. Target hemoglobin is 10–11.5 g/dL — pushing higher increases cardiovascular risk.
- IV iron (not oral): Appropriate when coexisting iron deficiency is confirmed. Oral iron is poorly absorbed due to hepcidin-mediated gut blockade in ACD.
- Blood transfusion: Reserved for hemoglobin below 7 g/dL or symptomatic patients with cardiovascular compromise.
- Anti-hepcidin therapies: Still experimental, but monoclonal antibodies targeting hepcidin or IL-6 (like tocilizumab) show promise in clinical trials.
A critical point: giving iron to a pure ACD patient without true iron deficiency is not just ineffective — it can fuel infections and tumor growth by providing iron to pathogens and malignant cells.
When to See a Doctor
If you have a chronic condition and are experiencing persistent fatigue, shortness of breath on exertion, or unusual pallor, ask your doctor to check a CBC and iron studies including ferritin, TIBC, and transferrin saturation. If your ferritin comes back in the 30–100 ng/mL range and you have active inflammation, request a soluble transferrin receptor level to clarify whether you also need iron supplementation.
Hemoglobin below 10 g/dL warrants a hematology referral, especially if the anemia isn’t improving with treatment of the underlying disease.
Frequently Asked Questions
Can anemia of chronic disease and iron deficiency anemia occur together?
Yes, and it’s common — especially in patients with inflammatory bowel disease, cancer, or chronic kidney disease. The coexistence makes diagnosis tricky because ferritin can be misleadingly normal. The sTfR/log ferritin index above 2.0 is the best way to unmask hidden iron deficiency in the setting of chronic inflammation.
Why is ferritin high in anemia of chronic disease?
Ferritin is an acute phase reactant, meaning it rises as part of the inflammatory response — independent of actual iron stores. Additionally, hepcidin traps iron inside macrophages, which increases intracellular ferritin production. A ferritin level that looks “normal” or “high” in an inflamed patient does not rule out concurrent iron deficiency.
Should I take iron supplements if I have anemia of chronic disease?
Only if testing confirms coexisting true iron deficiency. Blind iron supplementation in pure ACD is ineffective because hepcidin blocks iron absorption from the gut. If iron is needed, IV iron bypasses this block and is preferred over oral forms. Your doctor should check transferrin saturation and sTfR before deciding.
What hemoglobin level is typical in anemia of chronic disease?
Most patients with ACD have hemoglobin between 8–11 g/dL. It rarely drops below 8 g/dL unless there’s a second cause of anemia (like concurrent iron deficiency, B12 deficiency, or bone marrow suppression from chemotherapy). A hemoglobin below 8 g/dL should prompt investigation for additional contributing factors.
Is anemia of chronic disease the same as anemia of inflammation?
Yes. The terms are interchangeable, though “anemia of inflammation” is increasingly preferred because it more accurately describes the mechanism. Not all triggering conditions are traditionally considered “chronic” — acute critical illness and major surgery can also produce the same hepcidin-driven iron sequestration pattern over days to weeks.
